King Charles III has opened up about his ongoing battle with cancer during a recent visit to Guy’s Cancer Centre in London. The monarch, who was first diagnosed with an undisclosed type of cancer in 2024, is set to reduce his treatment regimen this year.
:max_bytes(150000):strip_icc():format(jpeg)/prince-charles-hospital-visit-1-051226-732d22bb6470474183b35d42817fe329.jpg)

On 11 May 2026, the King, now 77 years old, visited the renowned hospital to commemorate its 300th anniversary and to engage with innovative research projects conducted by both Guy’s Hospital and King’s College London, of which he holds many patronages. His visit highlighted the importance of cancer research and the advancements being made in the field.

During his time at the centre, King Charles met Raymond Burgess, a chemotherapy patient, and shared a candid moment regarding the unpleasant side effects of cancer treatment. Burgess described the annoying metallic taste left in his mouth due to the chemotherapy, prompting a sympathetic response from the monarch. “It’s an awful sort of metallic taste,” King Charles remarked, acknowledging how challenging it can be to maintain one’s appetite during such difficult times.
The King’s visit also extended beyond patient interaction, as he took the opportunity to learn about new treatments being developed using artificial intelligence and robotics. This engagement with medical professionals underscored his commitment to understanding the latest developments in healthcare, which is vital for ongoing patient care.
After announcing his cancer diagnosis in 2024, King Charles adhered closely to his doctors’ advice, and he has shared updates on his health journey with the public. In a recorded message broadcast in December, he expressed optimism regarding his treatment, indicating that the proactive measures taken had been beneficial. He noted, “Today, I am able to share with you the good news that thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders,’ my own schedule of cancer treatment can be reduced in the New Year.”
While the exact terminology “remission” has not been used, a spokesperson from Buckingham Palace confirmed that the King’s health had improved significantly. “His Majesty has responded exceptionally well to treatment, and his doctors advise that ongoing measures will now move into a precautionary phase,” the spokesperson explained. This reflects a cautious optimism for the future of the King’s treatment strategy.
The monarch has been vocal about the impact of his diagnosis not only on his life but also as a platform to raise awareness about cancer. His candid sharing aims to encourage and inspire the many individuals who face similar health challenges, with a focus on the importance of early detection and intervention.
As the King continues to navigate his health journey, his engagement with patients and healthcare professionals reinforces the significance of mental and emotional support during treatment. The royal family’s visibility in these matters serves to highlight the collective struggle against cancer and the advances in medical science that can offer hope to many.
The visit to Guy’s Cancer Centre represents more than just a ceremonial occasion; it is a testament to King Charles’s dedication to both his health and the ongoing fight against cancer. As he continues his journey, both the public and those in the realm of healthcare remain hopeful for his continued recovery and the further developments in cancer treatment that emerge from such strong advocacy and awareness.
